Regulatory7 Oct 2026, 03:24 pm
Panacea Biotec Reports September 2026 Dematerialisation Details
AI Summary
Panacea Biotec Ltd. has filed details of shares dematerialised during September 2026, as per SEBI regulations. The company reported a total of 6,11,09,526 shares dematerialised as of September 30, 2026. This includes 5,25,61,875 shares through NSDL and 85,47,651 shares through CDSL. The filing also includes a certificate from their RTA, Skyline Financial Services Pvt. Ltd., confirming these figures. This report is a routine regulatory disclosure.
Key Highlights
- Shares dematerialised during September 2026 reported.
- Total dematerialised shares as of Sept 30, 2026: 6,11,09,526.
- Breakdown provided for NSDL and CDSL dematerialisation.
- Regulatory compliance with SEBI (Depositories and Participants) Regulations.
- RTA certificate confirms dematerialisation status.
Price Impact
More from PANACEABIO